{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:20:06Z","timestamp":1786994406280,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.msard.2014.09.213","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T03:10:51Z","timestamp":1412824251000},"page":"58-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CD20+ T cells in multiple sclerosis"],"prefix":"10.1016","volume":"4","author":[{"given":"Raphael","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2014.09.213_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2014.09.213_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156652409787314516","article-title":"The contribution of gammadelta T cells to the pathogenesis of EAE and MS","volume":"9","author":"Blink","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.msard.2014.09.213_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.06.029","article-title":"Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients","volume":"180","author":"Cross","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2014.09.213_bib4","doi-asserted-by":"crossref","first-page":"R208","DOI":"10.1186\/ar3541","article-title":"Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects","volume":"13","author":"Eggleton","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.msard.2014.09.213_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/B978-0-444-52001-2.00029-7","article-title":"Cerebrospinal fluid analysis","volume":"122","author":"Giovannoni","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.msard.2014.09.213_bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2014.09.213_bib7","article-title":"CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination","author":"Holley","year":"20143650","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2014.09.213_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis","volume":"66","author":"Kebir","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2014.09.213_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbadis.2010.07.006","article-title":"Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models","volume":"1812","author":"Mars","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.msard.2014.09.213_bib10","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1400118","article-title":"Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients","author":"Palanichamy","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2014.09.213_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1742-2094-9-215","article-title":"Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis","volume":"9","author":"Romme Christensen","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2014.09.213_bib12","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.4049\/jimmunol.1100885","article-title":"B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients","volume":"187","author":"Schneider","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2014.09.213_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ncpneuro0832","article-title":"The role of regulatory T cells in multiple sclerosis","volume":"4","author":"Zozulya","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034814003174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034814003174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:36:32Z","timestamp":1761899792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034814003174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2211034814003174"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2014.09.213","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD20+ T cells in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2014.09.213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}